clopidogrel has been researched along with Rhabdomyolysis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bykov, K; Gagne, JJ; Glynn, RJ; Mittleman, MA; Schneeweiss, S | 1 |
Floyd, JS; Heckbert, SR; Kaspera, R; Kwok, PY; Lumley, T; Marciante, KD; Psaty, BM; Tamraz, B; Totah, RA; Weiss, NS; Wiggins, KL | 1 |
Mehra, MR; Park, MH; Scott, RL; Uber, PA | 1 |
Von Scheidt, W | 1 |
Burton, I; Burton, JR; Pearson, GJ | 1 |
Botey, A; Cases, A; Pou, M; Vera, M | 1 |
6 other study(ies) available for clopidogrel and Rhabdomyolysis
Article | Year |
---|---|
The Case-Crossover Design for Drug-Drug Interactions: Considerations for Implementation.
Topics: Administrative Claims, Healthcare; Azithromycin; Clarithromycin; Clopidogrel; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Drug Interactions; Electronic Health Records; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Implementation Science; Models, Statistical; Rhabdomyolysis; Risk Factors; Serotonin and Noradrenaline Reuptake Inhibitors; Treatment Outcome | 2019 |
A screening study of drug-drug interactions in cerivastatin users: an adverse effect of clopidogrel.
Topics: Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Aryl Hydrocarbon Hydroxylases; Case-Control Studies; Clopidogrel; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Platelet Aggregation Inhibitors; Pyridines; Rhabdomyolysis; Ticlopidine | 2012 |
Clopidogrel and rhabdomyolysis after heart transplantation.
Topics: Clopidogrel; Drug Interactions; Heart Transplantation; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Rhabdomyolysis; Ticlopidine | 2003 |
[Interaction of statins with clopidogrel].
Topics: Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Biotransformation; Cause of Death; Clinical Trials as Topic; Clopidogrel; Coronary Restenosis; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Platelet Aggregation Inhibitors; Prodrugs; Rhabdomyolysis; Risk Factors; Stents; Stroke; Survival Analysis; Ticlopidine | 2004 |
Clopidogrel-precipitated rhabdomyolysis in a stable heart transplant patient.
Topics: Clopidogrel; Cyclosporine; Drug Therapy, Combination; Female; Heart Transplantation; Humans; Middle Aged; Rhabdomyolysis; Simvastatin; Ticlopidine | 2007 |
[Massive rhabdomyolysis associated with the use of cerivastatin monotherapy].
Topics: Anticholesteremic Agents; Anuria; Clopidogrel; Coronary Artery Bypass; Humans; Hypercholesterolemia; Intracranial Thrombosis; Male; Middle Aged; Muscle Weakness; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Pyridines; Rhabdomyolysis; Ticlopidine | 2001 |